Literature DB >> 14619336

Decreased glucocorticoid binding affinity to glucocorticoid receptor is important in the poor response to steroid therapy of older-aged patients with severe bronchial asthma.

Young Joo Cho1, Kyung Eun Lee, Kyeung En Lee.   

Abstract

The aim of this study was to determine whether alterations in glucocorticoid (GC) to GC receptor (GC/GCR) binding affinity and the state of airway remodeling contribute to the poor response to GC therapy of severe bronchial asthma patients in old age. Peripheral blood mononuclear cells were obtained from two groups with severe asthma, 10 patients with steroid resistant (SR), 7 patients with steroid sensitive (SS), and 6 normal controls. GC/GCR binding affinity for dexamethasone was determined by using a radioligand binding assay with Scatchard analysis, and bronchial wall thickness in high-resolution computed tomography was used to determine the degree of airway remodeling. SR patients had decreased GC/GCR binding affinity (Kd = 24.3 +/- 9.55; p < 0.05) compared with the SS patients (Kd = 13.5 +/- 1.48; p < 0.05) and the normal controls (Kd = 4.24 +/- 1.09). The inner diameter of bronchi and the thickness of the bronchial wall of segmental and subsegmental bronchi were increased significantly in patients compared with normal controls. However, no significant differences were found between the SR and SS patients. Our results suggest that decreased GC/GCR binding affinity may be an important factor of clinical GC resistance in the acute exacerbation of chronic severe asthma in older-aged bronchial asthma patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14619336

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  7 in total

Review 1.  Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury.

Authors:  Nachiket M Godbole; Asif Alam Chowdhury; Neha Chataut; Shanjana Awasthi
Journal:  Inflammation       Date:  2022-07-02       Impact factor: 4.657

Review 2.  The role of pharmacogenetics in keloid scar treatment: A literature review.

Authors:  Tamara Searle; Faisal R Ali; Firas Al-Niaimi
Journal:  Scars Burn Heal       Date:  2020-08-13

3.  Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus.

Authors:  Juan Du; Min Li; Denghai Zhang; Xiaoyan Zhu; Weiwei Zhang; Wei Gu; Yinglu Feng; Xiaofeng Zhai; Changquan Ling
Journal:  Arthritis Res Ther       Date:  2009-07-14       Impact factor: 5.156

4.  Glucocorticoid receptor density and binding affinity in healthy horses and horses with systemic inflammatory response syndrome.

Authors:  C J Hoffman; H C McKenzie; M O Furr; A Desrochers
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

5.  An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease.

Authors:  D Rutkowski; F Syed; L C Matthews; D W Ray; D A McGrouther; R E B Watson; A Bayat
Journal:  Br J Dermatol       Date:  2015-07-28       Impact factor: 9.302

6.  Active Ingredients of Epimedii Folium and Ligustri Lucidi Fructus Balanced GR/HSP90 to Improve the Sensitivity of Asthmatic Rats to Budesonide.

Authors:  Xiufeng Tang; Xiaoxi Li; Honglei Nian; Yan Yang; Yuheng Chen; Xiujuan Wang; Liping Xu; Xinwei Yang; Renhui Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-11       Impact factor: 2.629

7.  Short palate, lung, and nasal epithelial clone 1 (SPLUNC1) level determines steroid-resistant airway inflammation in aging.

Authors:  Anil Kumar Jaiswal; Jyoti Yadav; Sangeet Makhija; Maninder Sandey; Amol Suryawanshi; Amit Kumar Mitra; Amarjit Mishra
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-01       Impact factor: 5.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.